trypan blue has been researched along with Invasiveness, Neoplasm in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Auersperg, N; Cheng, JC; Leung, PC | 1 |
| Farach-Carson, MC; Gurski, LA; Jia, X; Labrada, LN; Nguyen, NT; van Golen, KL; Xiao, L; Xu, X | 1 |
| Donato, NJ; Johnson, FM; Saigal, B; Talpaz, M | 1 |
3 other study(ies) available for trypan blue and Invasiveness, Neoplasm
| Article | Year |
|---|---|
TGF-beta induces serous borderline ovarian tumor cell invasion by activating EMT but triggers apoptosis in low-grade serous ovarian carcinoma cells.
Topics: Apoptosis; Benzamides; Caspase 3; Cystadenocarcinoma, Serous; Dioxoles; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; Humans; Neoplasm Invasiveness; Ovarian Neoplasms; Phosphorylation; Prognosis; RNA, Small Interfering; Smad2 Protein; Smad3 Protein; Transforming Growth Factor beta; Trypan Blue; Tumor Suppressor Protein p53 | 2012 |
Hyaluronan (HA) interacting proteins RHAMM and hyaluronidase impact prostate cancer cell behavior and invadopodia formation in 3D HA-based hydrogels.
Topics: Biotinylation; Blotting, Western; Cell Migration Assays; Cell Surface Extensions; Extracellular Matrix Proteins; Gene Knockdown Techniques; Humans; Hyaluronan Receptors; Hyaluronic Acid; Hyaluronoglucosaminidase; Hydrogels; Male; Neoplasm Invasiveness; Prostatic Neoplasms; Rheology; Trypan Blue; Tumor Cells, Cultured | 2012 |
Dasatinib (BMS-354825) tyrosine kinase inhibitor suppresses invasion and induces cell cycle arrest and apoptosis of head and neck squamous cell carcinoma and non-small cell lung cancer cells.
Topics: Adenosine Triphosphate; Antineoplastic Agents; Apoptosis; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Collagen; Crk-Associated Substrate Protein; Dasatinib; Dose-Response Relationship, Drug; Drug Combinations; Enzyme Inhibitors; Focal Adhesion Protein-Tyrosine Kinases; G1 Phase; Gentian Violet; Head and Neck Neoplasms; Humans; Immunoprecipitation; Inhibitory Concentration 50; Laminin; Lung Neoplasms; Neoplasm Invasiveness; Neovascularization, Pathologic; Paxillin; Phosphorylation; Protein-Tyrosine Kinases; Proteoglycans; Pyrimidines; Retinoblastoma Protein; S Phase; Signal Transduction; src-Family Kinases; Thiazoles; Time Factors; Trypan Blue | 2005 |